共有 50 笔近期内部人交易记录记录，涉及 Mineralys Therapeutics, Inc. (MLYS), 包括 21 笔买入 和 28 笔卖出. 内部人买入总额为 $61.26M 内部人卖出总额为 $2.63M.
近期活跃的重要内部人包括 Congleton Jon, Karydas Daphne, Ra Capital Management, L.p.. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — MLYS
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-31 |
Congleton Jon |
Chief Executive Officer |
知情卖出 |
453 |
$27.05 |
$12.25K |
705,051 |
| 2026-03-31 |
Karydas Daphne |
Director |
知情卖出 |
3,000 |
$25.00 |
$75K |
6,200 |
| 2026-03-30 |
Ra Capital Management, L.p. |
Director |
知情买入 |
58,300 |
$24.16 |
$1.41M |
5,825,521 |
| 2026-03-27 |
Ra Capital Management, L.p. |
Director |
知情买入 |
310,700 |
$23.67 |
$7.35M |
5,767,221 |
| 2026-03-17 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
417 |
$15.44 |
$6.44K |
5,000 |
| 2026-03-13 |
Rodman David Malcom |
Chief Medical Officer |
知情卖出 |
253 |
$27.82 |
$7.04K |
76,140 |
| 2026-03-12 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
6,348 |
$1.08 |
$6.86K |
25,395 |
| 2026-03-09 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
2,171 |
$16.00 |
$34.74K |
23,876 |
| 2026-03-04 |
Warren Eric |
Chief Commercial Officer |
未知 |
357,000 |
$13.24 |
$4.73M |
- |
| 2026-02-19 |
Akkaraju Srinivas |
10 Percent Owner |
限制性股票授予 (RSU) |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Sblendorio Glenn |
Director |
限制性股票授予 (RSU) |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Ra Capital Management, L.p. |
Director |
限制性股票授予 (RSU) |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Congleton Jon |
Chief Executive Officer |
限制性股票授予 (RSU) |
187,900 |
$28.06 |
$5.27M |
187,900 |
| 2026-02-19 |
Rodman David Malcom |
Chief Medical Officer |
限制性股票授予 (RSU) |
51,300 |
$28.06 |
$1.44M |
51,300 |
| 2026-02-19 |
Levy Adam Scott |
CFO and Secretary |
限制性股票授予 (RSU) |
39,900 |
- |
- |
48,538 |
| 2026-02-19 |
Dirocco Derek |
Director |
限制性股票授予 (RSU) |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Karydas Daphne |
Director |
限制性股票授予 (RSU) |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Slingsby Brian Taylor |
10 Percent Owner |
其他（卖出） |
6,200 |
- |
- |
- |
| 2026-02-19 |
Gold Alexander M |
Director |
限制性股票授予 (RSU) |
6,200 |
- |
- |
6,200 |
| 2026-02-17 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
417 |
$15.44 |
$6.44K |
5,417 |
| 2026-02-13 |
Rodman David Malcom |
Chief Medical Officer |
知情卖出 |
6,348 |
$27.58 |
$175.1K |
44,089 |
| 2026-02-12 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
6,349 |
$1.08 |
$6.86K |
31,743 |
| 2026-02-09 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
2,171 |
$16.00 |
$34.74K |
26,047 |
| 2026-01-20 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
416 |
$15.44 |
$6.42K |
5,834 |
| 2026-01-14 |
Rodman David Malcom |
Chief Medical Officer |
知情卖出 |
11,367 |
$32.61 |
$370.64K |
50,437 |
| 2026-01-13 |
Rodman David Malcom |
Chief Medical Officer |
知情卖出 |
7,709 |
$32.75 |
$252.47K |
61,804 |
| 2026-01-12 |
Congleton Jon |
Chief Executive Officer |
知情卖出 |
7,117 |
$33.15 |
$235.93K |
639,151 |
| 2026-01-12 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
6,348 |
$1.08 |
$6.86K |
38,092 |
| 2026-01-12 |
Levy Adam Scott |
CFO and Secretary |
知情卖出 |
10,758 |
$32.14 |
$345.72K |
8,638 |
| 2026-01-09 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
2,170 |
$16.00 |
$34.72K |
28,218 |
| 2026-01-05 |
Rodman David Malcom |
Chief Medical Officer |
期权行权 |
28,038 |
$1.08 |
$30.28K |
97,226 |
| 2026-01-02 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
20,168 |
$16.00 |
$322.69K |
84,018 |
| 2025-06-13 |
Rodman David Malcom |
Chief Medical Officer |
知情卖出 |
11,366 |
$14.60 |
$165.93K |
101,651 |
| 2025-06-12 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
6,348 |
$1.08 |
$6.86K |
95,229 |
| 2025-05-14 |
Rodman David Malcom |
Chief Medical Officer |
知情卖出 |
11,366 |
$15.29 |
$173.77K |
106,669 |
| 2025-05-12 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
6,349 |
$1.08 |
$6.86K |
101,577 |
| 2025-04-14 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
6,348 |
$1.08 |
$6.86K |
107,926 |
| 2025-04-11 |
Congleton Jon |
Chief Executive Officer |
知情卖出 |
15,319 |
$12.19 |
$186.8K |
862,289 |
| 2025-04-11 |
Levy Adam Scott |
CFO and Secretary |
知情卖出 |
10,757 |
$12.06 |
$129.68K |
215,340 |
| 2025-04-01 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
1,606 |
$1.08 |
$1.73K |
114,274 |
| 2025-03-13 |
Akkaraju Srinivas |
Director |
知情买入 |
600,000 |
$13.50 |
$8.1M |
5,674,916 |
| 2025-03-13 |
Ra Capital Management, L.p. |
Director |
知情买入 |
1,296,296 |
$13.50 |
$17.5M |
4,280,051 |
| 2025-03-13 |
Samsara Biocapital Gp, Llc |
10 Percent Owner |
知情买入 |
600,000 |
$13.50 |
$8.1M |
5,674,916 |
| 2025-03-13 |
Slingsby Brian Taylor |
10 Percent Owner |
知情买入 |
259,259 |
$13.50 |
$3.5M |
8,903,838 |
| 2025-03-12 |
Rodman David Malcom |
Chief Medical Officer |
期权行权（卖出） |
6,349 |
$1.08 |
$6.86K |
115,880 |
| 2025-02-13 |
Akkaraju Srinivas |
10 Percent Owner |
限制性股票授予 (RSU) |
32,900 |
$10.20 |
$335.58K |
32,900 |
| 2025-02-13 |
Sblendorio Glenn |
Director |
限制性股票授予 (RSU) |
32,900 |
$10.20 |
$335.58K |
32,900 |
| 2025-02-13 |
Ra Capital Management, L.p. |
Director |
限制性股票授予 (RSU) |
32,900 |
$10.20 |
$335.58K |
32,900 |
| 2025-02-13 |
Congleton Jon |
Chief Executive Officer |
限制性股票授予 (RSU) |
570,000 |
$10.20 |
$5.81M |
570,000 |
| 2025-02-13 |
Rodman David Malcom |
Chief Medical Officer |
限制性股票授予 (RSU) |
170,000 |
$10.20 |
$1.73M |
170,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
